SCHEMBL25810036

SCHEMBL25810036

OOCCCc1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 1/20 0.50
ALOX15 P16050 1/20 0.50
SLC6A2 P23975 2/20 0.47
HRH1 P35367 2/20 0.47
HRH3 Q9Y5N1 2/20 0.47
CHRM2 P08172 1/20 0.47
ADRA2C P18825 1/20 0.47
SLC6A4 P31645 1/20 0.47
SLC6A3 Q01959 1/20 0.47
KCNH2 Q12809 1/20 0.47
CACNA1C Q13936 1/20 0.47
SCN5A Q14524 1/20 0.47
HTR3E A5X5Y0 1/20 0.47
HTR3B O95264 1/20 0.47
HTR3A P46098 1/20 0.47
HTR3D Q70Z44 1/20 0.47
HTR3C Q8WXA8 1/20 0.47
TAAR1 Q96RJ0 2/20 0.46
CHRM4 P08173 1/20 0.46
HTR2C P28335 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27564195 0.92 IGF1R (0.52) IGF1RALOX15SLC6A2HRH1HRH3
SCHEMBL28544358 0.86 TAAR1 (0.50) IGF1RALOX15HTR3EHTR3BHTR3A
SCHEMBL9249000 0.82 SLC6A2 (0.64) IGF1RALOX15SLC6A2HRH1HRH3
SCHEMBL9672758 0.78 IDO1 (0.63) IGF1RALOX15SLC6A2HRH1HRH3
SCHEMBL21700176 0.78 TAAR1 (0.46) TAAR1SIGMAR1IDO1
SCHEMBL3655884 0.78 KCNH2 (0.47) IGF1RALOX15SLC6A2HRH1HRH3
SCHEMBL10365734 0.78 IGF1R (0.64) IGF1RALOX15KCNH2HTR3EHTR3B
SCHEMBL18050371 0.78 TAAR1 (0.62) IGF1RALOX15KCNH2HTR3EHTR3B
SCHEMBL8625873 0.77 IDO1 (0.61) SLC6A3HTR3ASIGMAR1HDAC3HDAC4
SCHEMBL28966782 0.76 IGF1R (0.61) IGF1RALOX15CHRM2KCNH2HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219914-A1 PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF Nuray Chemicals Private Limiited (IN) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219914-A1 PROCESS FOR PREPARING PITOLISANT HYDROCHLORIDE AND SOLID-STATE FORMS THEREOF PITHD1, MLN, TPP1 IGF1R 2867/4885ALOX15 3558/4885SLC6A2 295/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.